Publications by authors named "Timothy N Bullock"

Claim this Profile
S
Stereoselective Degradation of Diacylglycerol Kinases Potentiate T cell Activation and Tumor Cell Cytotoxicity.
Minhaj Shaikh, Surya Pravo Mookherjee, Claire C Weckerly, Adam H Libby, Aizhen Xiao, Timothy Nj Bullock

bioRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399.
Ryan D Gentzler, Liza C Villaruz, John C Rhee, Bethany Horton, Joseph Mock, Timothy N Bullock

Oncologist· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHC Class I Loss in Triple-negative Breast Cancer: A Potential Barrier to PD-1/PD-L1 Checkpoint Inhibitors.
Anna C Dusenbery, Joseph L Maniaci, Natalie D Hillerson, Erik A Dill, Timothy N Bullock

Am J Surg Pathol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHC class I loss in endometrial carcinoma: a potential resistance mechanism to immune checkpoint inhibition.
Lisa A Friedman, Timothy N Bullock, Emily A Sloan, Kari L Ring, Anne M Mills

Mod Pathol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of MHC Class I Expression in HPV-associated Cervical and Vulvar Neoplasia: A Potential Mechanism of Resistance to Checkpoint Inhibition.
Megan E Dibbern, Timothy N Bullock, Taylor M Jenkins, Linda R Duska, Mark H Stoler

Am J Surg Pathol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailoring early-phase clinical trial design to address multiple research objectives.
Nolan A Wages, Craig L Slingluff, Timothy N Bullock, Gina R Petroni

Cancer Immunol Immunother· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDO expression in breast cancer: an assessment of 281 primary and metastatic cases with comparison to PD-L1.
Erik A Dill, Patrick M Dillon, Timothy N Bullock, Anne M Mills

Mod Pathol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indoleamine-2,3-Dioxygenase in Non-Small Cell Lung Cancer: A Targetable Mechanism of Immune Resistance Frequently Coexpressed With PD-L1.
Ashley Volaric, Ryan Gentzler, Richard Hall, James H Mehaffey, Edward B Stelow, Timothy N Bullock

Am J Surg Pathol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanoma.
Marit M Melssen, Walter Olson, Nolan A Wages, Brian J Capaldo, Ileana S Mauldin, Timothy N Bullock

Oncoimmunology· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focused Ultrasound Immunotherapy for Central Nervous System Pathologies: Challenges and Opportunities.
Colleen T Curley, Natasha D Sheybani, Timothy N Bullock, Richard J Price

Theranostics· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?
Joseph M Obeid, Paul R Kunk, Victor M Zaydfudim, Timothy N Bullock, Craig L Slingluff

Cancer Immunol Immunother· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancer.
Kiley A Knapp, Eusebio S Pires, Sara J Adair, Arabinda Mandal, Anne M Mills, Timothy N Bullock

Oncotarget· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF-receptor superfamily agonists as molecular adjuvants for cancer vaccines.
Timothy Nj Bullock

Curr Opin Immunol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma.
Peter J Siska, Kathryn E Beckermann, Frank M Mason, Gabriela Andrejeva, Allison R Greenplate, Timothy N Bullock

JCI Insight· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulating CD27 to quantitatively and qualitatively shape adaptive immunity to cancer.
Timothy Nj Bullock

Curr Opin Immunol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Expression and Intratumoral Heterogeneity Across Breast Cancer Subtypes and Stages: An Assessment of 245 Primary and 40 Metastatic Tumors.
Erik A Dill, Alejandro A Gru, Kristen A Atkins, Lisa A Friedman, Margaret E Moore, Timothy N Bullock

Am J Surg Pathol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Virus Control Mediated by Licensed NK Cells Sets Primary CD8+ T Cell Dependence on CD27 Costimulation.
Jeffrey J Teoh, Awndre E Gamache, Alyssa L Gillespie, Michael D Stadnisky, Hideo Yagita, Timothy N J Bullock

J Immunol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: Correlation with tumor-infiltrating immune cells and clinical outcome.
Joseph M Obeid, Gulsun Erdag, Mark E Smolkin, Donna H Deacon, James W Patterson, Timothy N Bullock

Oncoimmunology· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD70 and IFN-1 selectively induce eomesodermin or T-bet and synergize to promote CD8+ T-cell responses.
Han Dong, Nathan A Franklin, Shane B Ritchea, Hideo Yagita, Martin J Glennie, Timothy N J Bullock

Eur J Immunol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-27 and the generation of CD8+ T-cell responses to peptide vaccines.
Timothy N J Bullock

Proc Natl Acad Sci U S A· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic influences that regulate dendritic cell function in tumors.
Han Dong, Timothy N J Bullock

Front Immunol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of tumor/dendritic cell interactions in the regulation of anti-tumor immunity: the good, the bad, and the ugly.
Kristian Michael Hargadon, Timothy N J Bullock

Front Immunol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: (CD)40 winks to prevent CD8+ T cell lethargy.
Timothy N J Bullock

J Leukoc Biol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD27 stimulation promotes the frequency of IL-7 receptor-expressing memory precursors and prevents IL-12-mediated loss of CD8(+) T cell memory in the absence of CD4(+) T cell help.
Han Dong, Nathan A Franklin, Drew J Roberts, Hideo Yagita, Martin J Glennie, Timothy N J Bullock

J Immunol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self MHC class I-licensed NK cells enhance adaptive CD8 T-cell viral immunity.
Michael D Stadnisky, Xuefang Xie, Ebony R Coats, Timothy N Bullock, Michael G Brown

Blood· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis